Insider · CIK 0001927056
Max A. Milbury
Files at PMN (ProMIS Neurosciences Inc.). First filing Oct 6, 2025, latest Oct 6, 2025.
In brief
Max A. Milbury files SEC Form 4 as officer at PMN (ProMIS Neurosciences Inc.). Since Oct 6, 2025, Max A. Milbury has reported 1 open-market buy worth $15k and 0 open-market sells worth $0, the latest filed on Oct 6, 2025.
A track record needs three past buys with six months of prices behind them; Max A. Milbury has 0, so none is measured yet.
The newest scored trade: bought $15k of PMN on Oct 3, 2025, filed Oct 6, 2025, scored 26 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PMN: ProMIS Neurosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | PMNbuy ProMIS Neurosciences Inc. | $15k 30,392 shares | +203% | +28% from low-61% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +18,167 | $0.00 | $0 | 18,167 | May 22, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Common Shares | +6,595 | $12.13 | $80k | 8,409 | Feb 5, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Warrants to purchase Common Sharesderivative | +6,595 | - | - | 6,595 | Feb 5, 2026 |
| Oct 3, 2025 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Shares | +30,392 | $0.49 | $15k | 45,389 | Oct 6, 2025 |
| Sep 22, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Sep 24, 2025 |
| Nov 18, 2024 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Nov 20, 2024 |
| Oct 26, 2023 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Oct 30, 2023 |
Questions about Max A. Milbury
Answered from the filings on this page, as of the latest one.
Is Max A. Milbury buying or selling?
Not in the last 12 months. Max A. Milbury's latest open-market trade on SEC Form 4 was bought $15k of PMN on Oct 3, 2025.
How did Max A. Milbury's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Max A. Milbury has 0.
Where does Max A. Milbury file Form 4?
Max A. Milbury has filed Form 4 at PMN (ProMIS Neurosciences Inc.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.